U.S. Electric Utilities Stock News

If you are wondering whether Bloom Energy is still worth pursuing after its huge run, or if the easy money has already been made, this article unpacks what the market might be getting right and wrong about the stock. The share price has cooled slightly in the very short term, slipping around 0.8% over the last week and 1.3% over the past month. However, that comes after a 280.1% year-to-date gain and a 267.0% increase over the last year. Behind those moves, investors have been reacting to a...

GrafTech International Ltd. ( NYSE:EAF ) shareholders would be excited to see that the share price has had a great...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

RXO (RXO) is back in focus after a string of cautious analyst updates and a negative outlook revision from S&P Global, all pointing to the same issue: margin pressure is getting harder to ignore. See our latest analysis for RXO. The market has been quick to price in those tightening margins, with RXO’s 7 day share price return of minus 9.6 percent and a year to date share price return of minus 42.7 percent underscoring fading momentum despite a recent 30 day share price rebound of 18.2...

In its recently reported third quarter, Federated Hermes posted revenue growth of 14.9% year on year, beating analyst estimates by 5.5% and delivering a stronger-than-expected earnings performance. This upside surprise was powered by record net sales of equity funds and rising demand for the firm’s MDT equity and alternative quantitative strategies, underscoring investor appetite for its quantitative capabilities. Next, we’ll examine how this earnings beat, underpinned by record equity fund...

Cytokinetics has secured U.S. FDA approval for MYQORZO (aficamten) tablets to treat adults with symptomatic obstructive hypertrophic cardiomyopathy, its first approved medicine and one that comes with a boxed warning and a REMS program due to heart failure risk. The label’s flexible dosing, lack of mandatory drug–drug interaction monitoring, and supporting Phase 3 SEQUOIA-HCM data could meaningfully influence how cardiologists position MYQORZO against existing therapies in oHCM care. We’ll...

Earlier this month, Revvity, Inc. introduced Signals Xynthetica, an AI Models-as-a-Service offering within its Revvity Signals platform to support AI-augmented molecular and materials design by unifying in-silico generation, predictive modeling, and experimental validation in a governed environment. An interesting angle is that Signals Xynthetica embeds AI models directly into real-world lab workflows, linking predictions with wet-lab outcomes to create a continuously learning discovery loop...

As the U.S. market experiences a resurgence with major stock indexes closing sharply higher for the second consecutive day, small-cap stocks are gaining attention amid this renewed risk appetite. In this dynamic environment, identifying promising small-cap opportunities involves looking at companies with solid fundamentals and potential growth catalysts that align well with current market trends.

J.B. Hunt Transport Services (JBHT) heads into its upcoming Q4 earnings with expectations running higher than usual, following a strong Q3 and a clear uptick in bullish options activity around the stock. See our latest analysis for J.B. Hunt Transport Services. The strong Q3 surprise and recent bullish options flow have helped fuel a sharp rebound. J.B. Hunt’s roughly 50 percent 3 month share price return signals that momentum is clearly building rather than fading. If this kind of move has...

As the U.S. stock market experiences a resurgence with major indexes posting gains, driven by a rally in tech stocks, investors are increasingly looking for opportunities that may be undervalued. In this environment of renewed risk appetite and shifting sector performances, identifying stocks that offer strong fundamentals at attractive valuations becomes crucial for those seeking potential value in their portfolios.

Coherent Corp. ( NYSE:COHR ) shares have continued their recent momentum with a 33% gain in the last month alone. The...

As the U.S. stock market experiences a resurgence, with major indexes like the S&P 500 and Nasdaq posting weekly gains amid a tech rally, investor confidence appears to be on the rise. In such an environment, growth companies with high insider ownership can signal strong internal belief in their long-term potential, making them attractive considerations for those looking to align with management's vision.

As of December 19, 2025, major stock indexes in the United States have shown a notable upswing, with the tech-heavy Nasdaq and benchmark S&P 500 posting weekly gains amid a continued rally in technology shares. This positive momentum in broader markets can create an intriguing backdrop for exploring investment opportunities across various sectors. Penny stocks, while often considered speculative due to their lower price points and smaller company profiles, remain relevant as they can offer...

Key Insights Insiders appear to have a vested interest in Freedom Holding's growth, as seen by their sizeable ownership...

Alto Ingredients, Inc. ( NASDAQ:ALTO ) shares have continued their recent momentum with a 41% gain in the last month...

Potential 374Water Inc. ( NASDAQ:SCWO ) shareholders may wish to note that the Interim President, Stephen Jones...

Opera Limited's ( NASDAQ:OPRA ) investors are due to receive a payment of $0.39 per share on 14th of January. The...

The board of Lamb Weston Holdings, Inc. ( NYSE:LW ) has announced that the dividend on 27th of February will be...

Some Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) shareholders may be a little concerned to see that the Independent...

Atour Lifestyle Holdings Limited ( NASDAQ:ATAT ), might not be a large cap stock, but it saw a decent share price...

Wondering if Lantheus Holdings is quietly turning into a bargain, or if the market already sees something you do not? Let us break down what the recent numbers are really saying about its value. The stock is down 27.6% over the last year and 25.8% year to date, but it has bounced 18.1% in the last month, a pattern that often signals investors are rethinking the story. That shift in sentiment comes as Lantheus continues to build on its diagnostics and radiopharmaceutical portfolio, including...

Wondering if SharpLink Gaming at around $9.81 is a hidden value opportunity or a value trap? You are not alone; this stock has started to pop up on more radars lately. Over the last week the share price is up 3.2%, roughly matching its 3.0% gain over the past month, but the real eye catcher is the 21.4% return year to date after a tough 3 year slide of 74.1%. Recent headlines have focused on SharpLink Gaming's strategic push deeper into sports betting technology and partnerships with media...

If you are wondering whether DraftKings at around $34 a share is a bargain or a bubble, you are not alone. This article walks through what the numbers really say about its value. Over the last month the stock is up 14.1%, but that comes after a choppy run, with the shares down 3.9% over the past week, 5.7% year to date, and 10.8% over the last year. The 3 year return still sits at an eye catching 196.7%. Those swings have been underpinned by ongoing state by state legalization and expansion...

Earlier this month, ExlService Holdings completed a US$63.37 million repurchase of 1,551,970 shares at US$40.83 each from Orogen Echo LLC, alongside reporting a quarter of 12% revenue growth and 11% adjusted EPS growth powered by its data and AI offerings. At the same time, EXL’s full migration of its LifePRO Digital Suite to Amazon Web Services highlights how its AI-enabled, cloud-based platforms are reshaping life and annuity operations for global insurers. Next, we’ll explore how EXL’s...